跳至主要内容
临床试验/ACTRN12612001288819
ACTRN12612001288819招募中未知

For obese people with fatty liver, dose Yin-Chen-Hao-Tang has effect on fatty liver degree?

Taoyuan Chang Gung Memorial Hospital of The Chang Gung Medical Fundation0 个研究点目标入组 20 人开始时间: 2012年12月12日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
20 Years 至 65 Years(—)
性别
All

入选标准

  • participant who is obese with fatty liver that is diagnosed at outpatient department

排除标准

  • 1.Patient has ALT and AST levels of over 1000 u/L
  • 2.Patient has a-Fetoprotein (AFP) levels of over 2 upper laboratory norms.
  • 3.Patient is pregnant
  • 4.Patients with alcoholic or drug abuse
  • 5.Patients treatment with drugs, e.g. corticosteroids, high-dose estrogens, methotrexate, amiodarone, calcium channel blockers, spironolactone, sulfasalazine, naproxen, or oxacillin.
  • 6.Patient has total cholesterol (TC) and triglyceride (TG) over 300 u/L
  • 7.Patient has fast plasma glucose over 126 mg/dl, and postprandial plasma glucose over 200mg/dl
  • 8.Patient has HBsAg positive
  • 9.Patient has Anti-HCV positive
  • 10.Patient with a malignancy which can influence prognosis
  • 11.Patient has BP less than 90/50 mm/Hg

研究者

发起方
Taoyuan Chang Gung Memorial Hospital of The Chang Gung Medical Fundation

相似试验